Jun-Ma Yu
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Jun-Ma Yu has a total of 97 co-authors. Here are the top co-authors by number of shared publications:
Rui Hu
Department of Anesthesiology, The Third Affiliated Hospital of Anhui Medical University (The First People’s Hospital of Hefei), Hefei, China
9 shared publicationsJing-Yi Niu
Department of Anesthesiology, The Third Affiliated Hospital of Anhui Medical University (The First People’s Hospital of Hefei), Hefei, China
8 shared publicationsLining Wu
Department of Anesthesiology, The First Affiliated Hospital of Anhui Medical University, Hefei 230061, PR China; Department of Anesthesiology, The Third Affiliated Hospital of Anhui Medical University, Hefei 230022, PR China
8 shared publicationsNa Yang
8 shared publicationsHao Sun
Department of Anesthesiology, the Third Affiliated Hospital of Anhui Medical University (The First People’s Hospital of Hefei), Hefei, Anhui, People’s Republic of China
7 shared publicationsPeng Sun
Department of Anesthesiology, The Third Affiliated Hospital of Anhui Medical University (The First People’s Hospital of Hefei), Hefei, China
6 shared publications
Latest Publications
- Open Access
- 26 May 2026
- Published by Springer Nature in EMBO Reports
- Vol. 27 (13) , 3665-3688
Kdm6b-mediated epigenetic coordination of temporal precision during motor neuron differentiation
Histone modifiers are crucial for instructing multiple-stage cellular differentiation, yet the mechanisms underlying their temporal precision remain enigmatic. Here, we demonstrate that the H3K27 demethylase Kdm6b acts as an epigenetic regulator, coordinating stepwise motor neuron (MN) differentiation through sequential partnerships with stage-specific transcription factors (TFs). Genome-wide profiling reveals a progressive gain in Kdm6b occupancy, especially at distal regulatory elements, as differentiation proceeds. Kdm6b dynamically remodels chromatin landscapes by coordinating H3K27me3 removal with H3K27ac and H3K4me1 acquisition, thereby enabling timed gene activation from MN specification to maturation. Stage-specific inhibition of Kdm6b compromises the ordered expression of developmental genes. Mechanistically, Kdm6b interacts with temporal TFs over time to ensure precise transcriptional control and MN differentiation. Our work elucidates how a single epigenetic regulator achieves temporal fidelity of stepwise MN development, providing insight into epigenetic regulation of developmental timing.
- 26 May 2026
- Published by Springer Nature in EMBO Reports
- Vol. 27 (13) , 3665-3688
Open AccessKdm6b-mediated epigenetic coordination of temporal precision during motor neuron differentiation
Histone modifiers are crucial for instructing multiple-stage cellular differentiation, yet the mechanisms underlying their temporal precision remain enigmatic. Here, we demonstrate that the H3K27 demethylase Kdm6b acts as an epigenetic regulator, coordinating stepwise motor neuron (MN) differentiation through sequential partnerships with stage-specific transcription factors (TFs). Genome-wide profiling reveals a progressive gain in Kdm6b occupancy, especially at distal regulatory elements, as differentiation proceeds. Kdm6b dynamically remodels chromatin landscapes by coordinating H3K27me3 removal with H3K27ac and H3K4me1 acquisition, thereby enabling timed gene activation from MN specification to maturation. Stage-specific inhibition of Kdm6b compromises the ordered expression of developmental genes. Mechanistically, Kdm6b interacts with temporal TFs over time to ensure precise transcriptional control and MN differentiation. Our work elucidates how a single epigenetic regulator achieves temporal fidelity of stepwise MN development, providing insight into epigenetic regulation of developmental timing.
- Open Access
- 23 May 2026
- Published by Elsevier in Cell Reports
- Vol. 45 (6) , 117426
Green light relieves stress-induced anxiety-like behaviors via visual-to-prefrontal projections in mice
- 23 May 2026
- Published by Elsevier in Cell Reports
- Vol. 45 (6) , 117426
Open AccessGreen light relieves stress-induced anxiety-like behaviors via visual-to-prefrontal projections in mice
- Open Access
- 9 December 2025
- Published by Springer Nature in European Journal of Medical Research
- Vol. 31 (1)
Effect of intratracheal dexmedetomidine combined with ropivacaine at various times prior to tracheal intubation in patients undergoing thyroidectomy: a randomized clinical trial
Optimizing the clinical workflow, this study evaluated the impact of varying the time interval between topical airway anesthesia with a dexmedetomidineR
- 9 December 2025
- Published by Springer Nature in European Journal of Medical Research
- Vol. 31 (1)
Open AccessEffect of intratracheal dexmedetomidine combined with ropivacaine at various times prior to tracheal intubation in patients undergoing thyroidectomy: a randomized clinical trial
Optimizing the clinical workflow, this study evaluated the impact of varying the time interval between topical airway anesthesia with a dexmedetomidineR
- Open Access
- 1 December 2025
- Published by Taylor & Francis in Drug Design, Development and Therapy
- Vol. ume 19, 10621-10631
The Effect of Local Infiltration of Dexmedetomidine as an Adjuvant on Breakthrough Pain During Epidural Labor Analgesia: A Randomized Controlled Trial
Purpose: Evaluation of the effectiveness of local dexmedetomidine and ropivacaine administration prior to epidural puncture in reducing breakthrough pain during labor analgesia. Methods: A total of 267 parturients were enrolled in this study and allocated to three groups: Group C (n=86) received 0 μg/kg (control), Group D1 (n=87) received 0.4 μg/kg, and Group D2 (n=92) received 0.6 μg/kg. Dexmedetomidine combined with 0.5% ropivacaine (3 mL) was applied locally at the epidural puncture site. The primary outcome was the incidence of breakthrough pain during labor. The secondary outcomes included visual analog scale (VAS) score at the puncture site on days 3, 7, and 42 postpartum; the Edinburgh Postnatal Depression Scale (EPDS) score and Pittsburgh Sleep Quality Index score at prenatal, 7–day postpartum, and 42–day postpartum. In addition, the Apgar scores and umbilical artery blood gas status at 1 and 5 minute and the need for neonatal ward admission were also collected. Results: The incidence of breakthrough pain episodes was markedly lower in the Group D1 (23 of 87 [26.4%] vs 43 of 86 [50.0%]; odds ratio [OR], 0.395; 95% confidence interval [CI], 0.190– 0.675; p = 0.002) and Group D2 (21 of 92 [22.8%] vs 43 of 86 [50.0%]; OR, 0.296; 95% CI, 0.155– 0.564; p < 0.001) than in the Group C. Postpartum analysis revealed significantly lower VAS scores for puncture site pain in Groups D1 and D2 than in Group C at the 3-days postpartum (p < 0.001). Parturients in Group D2 demonstrated a significant reduction in EPDS scores compared to Group C at postpartum day 7. Conclusion: Administering local infiltration of 0.4 μg/kg or 0.6 μg/kg dexmedetomidine prior to epidural puncture in parturients undergoing elective labor analgesia has been shown to be effective in decreasing the incidence of breakthrough pain during labor analgesia. Trial Registration: The trial has been registered in the Chinese Clinical Trials Registry (ChiCTR2400083244) https://www.chictr.org.cn/showproj.html?proj=227790.
- 1 December 2025
- Published by Taylor & Francis in Drug Design, Development and Therapy
- Vol. ume 19, 10621-10631
Open AccessThe Effect of Local Infiltration of Dexmedetomidine as an Adjuvant on Breakthrough Pain During Epidural Labor Analgesia: A Randomized Controlled Trial
Purpose: Evaluation of the effectiveness of local dexmedetomidine and ropivacaine administration prior to epidural puncture in reducing breakthrough pain during labor analgesia. Methods: A total of 267 parturients were enrolled in this study and allocated to three groups: Group C (n=86) received 0 μg/kg (control), Group D1 (n=87) received 0.4 μg/kg, and Group D2 (n=92) received 0.6 μg/kg. Dexmedetomidine combined with 0.5% ropivacaine (3 mL) was applied locally at the epidural puncture site. The primary outcome was the incidence of breakthrough pain during labor. The secondary outcomes included visual analog scale (VAS) score at the puncture site on days 3, 7, and 42 postpartum; the Edinburgh Postnatal Depression Scale (EPDS) score and Pittsburgh Sleep Quality Index score at prenatal, 7–day postpartum, and 42–day postpartum. In addition, the Apgar scores and umbilical artery blood gas status at 1 and 5 minute and the need for neonatal ward admission were also collected. Results: The incidence of breakthrough pain episodes was markedly lower in the Group D1 (23 of 87 [26.4%] vs 43 of 86 [50.0%]; odds ratio [OR], 0.395; 95% confidence interval [CI], 0.190– 0.675; p = 0.002) and Group D2 (21 of 92 [22.8%] vs 43 of 86 [50.0%]; OR, 0.296; 95% CI, 0.155– 0.564; p < 0.001) than in the Group C. Postpartum analysis revealed significantly lower VAS scores for puncture site pain in Groups D1 and D2 than in Group C at the 3-days postpartum (p < 0.001). Parturients in Group D2 demonstrated a significant reduction in EPDS scores compared to Group C at postpartum day 7. Conclusion: Administering local infiltration of 0.4 μg/kg or 0.6 μg/kg dexmedetomidine prior to epidural puncture in parturients undergoing elective labor analgesia has been shown to be effective in decreasing the incidence of breakthrough pain during labor analgesia. Trial Registration: The trial has been registered in the Chinese Clinical Trials Registry (ChiCTR2400083244) https://www.chictr.org.cn/showproj.html?proj=227790.
- Open Access
- 26 September 2025
- Published by Springer Nature in European Journal of Medical Research
- Vol. 30 (1) , 1-9
Comparison of liposomal bupivacaine erector spinae plane block versus wound infiltration for postoperative analgesia and quality of recovery in lumbar fusion surgery: a randomized controlled trial
This study aimed to compare the efficacy of liposomal bupivacaine ultrasound-guided erector spinae plane block (ESPB) with wound infiltration (WI) on postoperative analgesia and quality of recovery in patients undergoing lumbar spinal fusion surgery. Eighty patients scheduled for lumbar fusion surgery were randomized to receive either WI (n = 40) or ultrasound-guided bilateral ESPB (n = 40). Pain intensity in the postanesthesia care unit (PACU) and at 6, 12, 24, 48 and 72 h after surgery was the primary outcome. The secondary outcomes included quality of recovery, intraoperative opioid consumption, use of rescue analgesics within 72 h and postoperative lumbar function. Adverse events were recorded. Compared with the WI group, the ESPB group demonstrated lower pain scores in the PACU (median [IQR]: 2 [1,2] vs. 2 [2,3]; median difference, −1; 95% confidence interval [CI] −2 to −1; P < 0.001) and at 6 h after surgery (median [IQR]: 2 [1,2] vs. 3 [2,3]; median difference, −1; 95% CI −1 to −1; P < 0.001). There were no significant differences in VAS scores between the two groups beyond 6 h. In addition, the ESPB group had higher Quality of Recovery-15 scale scores at 72 h after surgery (mean ± SD: [119.49 ± 5.01] vs. [116.61 ± 4.33]; P = 0.009). The doses of sufentanil (median [IQR]: 20 [20,22] vs. 25 [23,30]; P < 0.001) and remifentanil (median [IQR]: 680 [560,850] vs 775 [647.5,1005]; P = 0.042) were significantly lower in the ESPB group than those in the WI group. However, there were no differences in the Oswestry Disability Index between the groups at 1 or 3 months after surgery. For patients undergoing lumbar spinal fusion surgery, compared with WI, ultrasound‑guided ESPB with liposomal bupivacaine provided a slight advantage in improving postoperative analgesia and quality of recovery, and reduced intraoperative opioid consumption. However, these findings probably lack clinical significance. Trial registration: This study was registered at the Chinese Clinical Trial Registry ( http://www.chictr.org.cn , ChiCTR240084425; Registration Date: May 16, 2024).
- 26 September 2025
- Published by Springer Nature in European Journal of Medical Research
- Vol. 30 (1) , 1-9
Open AccessComparison of liposomal bupivacaine erector spinae plane block versus wound infiltration for postoperative analgesia and quality of recovery in lumbar fusion surgery: a randomized controlled trial
This study aimed to compare the efficacy of liposomal bupivacaine ultrasound-guided erector spinae plane block (ESPB) with wound infiltration (WI) on postoperative analgesia and quality of recovery in patients undergoing lumbar spinal fusion surgery. Eighty patients scheduled for lumbar fusion surgery were randomized to receive either WI (n = 40) or ultrasound-guided bilateral ESPB (n = 40). Pain intensity in the postanesthesia care unit (PACU) and at 6, 12, 24, 48 and 72 h after surgery was the primary outcome. The secondary outcomes included quality of recovery, intraoperative opioid consumption, use of rescue analgesics within 72 h and postoperative lumbar function. Adverse events were recorded. Compared with the WI group, the ESPB group demonstrated lower pain scores in the PACU (median [IQR]: 2 [1,2] vs. 2 [2,3]; median difference, −1; 95% confidence interval [CI] −2 to −1; P < 0.001) and at 6 h after surgery (median [IQR]: 2 [1,2] vs. 3 [2,3]; median difference, −1; 95% CI −1 to −1; P < 0.001). There were no significant differences in VAS scores between the two groups beyond 6 h. In addition, the ESPB group had higher Quality of Recovery-15 scale scores at 72 h after surgery (mean ± SD: [119.49 ± 5.01] vs. [116.61 ± 4.33]; P = 0.009). The doses of sufentanil (median [IQR]: 20 [20,22] vs. 25 [23,30]; P < 0.001) and remifentanil (median [IQR]: 680 [560,850] vs 775 [647.5,1005]; P = 0.042) were significantly lower in the ESPB group than those in the WI group. However, there were no differences in the Oswestry Disability Index between the groups at 1 or 3 months after surgery. For patients undergoing lumbar spinal fusion surgery, compared with WI, ultrasound‑guided ESPB with liposomal bupivacaine provided a slight advantage in improving postoperative analgesia and quality of recovery, and reduced intraoperative opioid consumption. However, these findings probably lack clinical significance. Trial registration: This study was registered at the Chinese Clinical Trial Registry ( http://www.chictr.org.cn , ChiCTR240084425; Registration Date: May 16, 2024).
- Open Access
- 1 November 2024
- Published by Taylor & Francis in Drug Design, Development and Therapy
- Vol. ume 18, 5461-5472
Effects of Esketamine Combined with Dexmedetomidine on Early Postoperative Cognitive Function in Elderly Patients Undergoing Lumbar Spinal Surgery: A Double-Blind Randomized Controlled Clinical Trial
Background: Postoperative cognitive dysfunction (POCD) is a common complication after surgery in elderly patients, and its prevalence can be up to 25.6% at one week after noncardiac surgery. This study mainly evaluates the combined effects of esketamine and dexmedetomidine on the incidence of POCD in elderly patients undergoing lumbar spine surgery and explores the underlying mechanisms. Methods: A total of 162 elderly patients undergoing lumbar spine surgery were randomized into three groups: esketamine combined with dexmedetomidine group (ED group), esketamine group (E group), and dexmedetomidine group (D group). Primary outcome measures included the incidence of POCD on the first postoperative day. Secondary outcomes included the incidence of POCD on the third postoperative day, first postoperative day serum levels of neuron-specific enolase (NSE) and calcium-binding protein β (S100β), patient visual analog scale (VAS) scores at 2, 24, and 48 hours postoperatively, and the incidence of adverse events. Results: The incidence of POCD on the first postoperative day was significantly lower in the ED group compared to the E group (P = 0.017), with no significant differences when compared to the D group (P = 0.064). The levels of serum NSE in patients in the ED group on the first postoperative day were significantly lower than those in E group and D group (ED group vs E group, P = 0.028; ED group vs D group, P = 0.048). The results for the S100β were similar to those for the NSE (ED group vs E group, P = 0.005; ED group vs D group, P = 0.011). Conclusion: The combination of esketamine and dexmedetomidine effectively reduces the incidence of POCD on the first postoperative day in elderly patients undergoing lumbar spine surgery.
- 1 November 2024
- Published by Taylor & Francis in Drug Design, Development and Therapy
- Vol. ume 18, 5461-5472
Open AccessEffects of Esketamine Combined with Dexmedetomidine on Early Postoperative Cognitive Function in Elderly Patients Undergoing Lumbar Spinal Surgery: A Double-Blind Randomized Controlled Clinical Trial
Background: Postoperative cognitive dysfunction (POCD) is a common complication after surgery in elderly patients, and its prevalence can be up to 25.6% at one week after noncardiac surgery. This study mainly evaluates the combined effects of esketamine and dexmedetomidine on the incidence of POCD in elderly patients undergoing lumbar spine surgery and explores the underlying mechanisms. Methods: A total of 162 elderly patients undergoing lumbar spine surgery were randomized into three groups: esketamine combined with dexmedetomidine group (ED group), esketamine group (E group), and dexmedetomidine group (D group). Primary outcome measures included the incidence of POCD on the first postoperative day. Secondary outcomes included the incidence of POCD on the third postoperative day, first postoperative day serum levels of neuron-specific enolase (NSE) and calcium-binding protein β (S100β), patient visual analog scale (VAS) scores at 2, 24, and 48 hours postoperatively, and the incidence of adverse events. Results: The incidence of POCD on the first postoperative day was significantly lower in the ED group compared to the E group (P = 0.017), with no significant differences when compared to the D group (P = 0.064). The levels of serum NSE in patients in the ED group on the first postoperative day were significantly lower than those in E group and D group (ED group vs E group, P = 0.028; ED group vs D group, P = 0.048). The results for the S100β were similar to those for the NSE (ED group vs E group, P = 0.005; ED group vs D group, P = 0.011). Conclusion: The combination of esketamine and dexmedetomidine effectively reduces the incidence of POCD on the first postoperative day in elderly patients undergoing lumbar spine surgery.
- Open Access
- 1 September 2024
- Published by Taylor & Francis in International Journal of Nanomedicine
- Vol. ume 19, 9035-9053
Ischemic-Preconditioning Induced Serum Exosomal miR-133a-3p Improved Post-Myocardial Infarction Repair via Targeting LTBP1 and PPP2CA
Background: Ischemic preconditioning-induced serum exosomes (IPC-exo) protected rat heart against myocardial ischemia/reperfusion injury. However, whether IPC-exo regulate replacement fibrosis after myocardial infarction (MI) and the underlying mechanisms remain unclear. MicroRNAs (miRs) are important cargos of exosomes and play an essential role in cardioprotection. We aim to investigate whether IPC-exo regulate post-MI replacement fibrosis by transferring cardioprotective miRs and its action mechanism. Methods: Exosomes obtained from serum of adult rats in control (Con-exo) and IPC groups were identified and analyzed, subsequently intracardially injected into MI rats following ligation. Their miRs profiles were identified using high-throughput miR sequencing to identify target miRs for bioinformatics analysis. Luciferase reporter assays confirmed target genes of selected miRs. IPC-exo transfected with selected miRs antagomir or NC were intracardially administered to MI rats post-ligation. Cardiac function and degree of replacement fibrosis were detected 4 weeks post-MI. Results: IPC-exo exerted cardioprotective effects against excessive replacement fibrosis. MiR sequencing and RT-qPCR identified miR-133a-3p as most significantly different between IPC-exo and Con-exo. MiR-133a-3p directly targeted latent transforming growth factor beta binding protein 1 (LTBP1) and protein phosphatase 2, catalytic subunit, alpha isozyme (PPP2CA). KEGG analysis showed that transforming growth factor-β (TGF-β) was one of the most enriched signaling pathways with miR-133a-3p. Comparing to injection of IPC-exo transfected with miR-133a-3p antagomir NC, injecting IPC-exo transfected with miR-133a-3p antagomir abolished protective effects of IPC-exo on declining excessive replacement fibrosis and cardiac function enhancement, while increasing the messenger RNA and protein expression of LTBP1, PPP2CA, and TGF-β 1in MI rats. Conclusion: IPC-exo inhibit excessive replacement fibrosis and improve cardiac function post-MI by transferring miR-133a-3p, the mechanism is associated with directly targeting LTBP1 and PPP2CA, and indirectly regulating TGF-β pathway in rats. Our finding provides potential therapeutic effect of IPC-induced exosomal miR-133a-3p for cardiac repair.
- 1 September 2024
- Published by Taylor & Francis in International Journal of Nanomedicine
- Vol. ume 19, 9035-9053
Open AccessIschemic-Preconditioning Induced Serum Exosomal miR-133a-3p Improved Post-Myocardial Infarction Repair via Targeting LTBP1 and PPP2CA
Background: Ischemic preconditioning-induced serum exosomes (IPC-exo) protected rat heart against myocardial ischemia/reperfusion injury. However, whether IPC-exo regulate replacement fibrosis after myocardial infarction (MI) and the underlying mechanisms remain unclear. MicroRNAs (miRs) are important cargos of exosomes and play an essential role in cardioprotection. We aim to investigate whether IPC-exo regulate post-MI replacement fibrosis by transferring cardioprotective miRs and its action mechanism. Methods: Exosomes obtained from serum of adult rats in control (Con-exo) and IPC groups were identified and analyzed, subsequently intracardially injected into MI rats following ligation. Their miRs profiles were identified using high-throughput miR sequencing to identify target miRs for bioinformatics analysis. Luciferase reporter assays confirmed target genes of selected miRs. IPC-exo transfected with selected miRs antagomir or NC were intracardially administered to MI rats post-ligation. Cardiac function and degree of replacement fibrosis were detected 4 weeks post-MI. Results: IPC-exo exerted cardioprotective effects against excessive replacement fibrosis. MiR sequencing and RT-qPCR identified miR-133a-3p as most significantly different between IPC-exo and Con-exo. MiR-133a-3p directly targeted latent transforming growth factor beta binding protein 1 (LTBP1) and protein phosphatase 2, catalytic subunit, alpha isozyme (PPP2CA). KEGG analysis showed that transforming growth factor-β (TGF-β) was one of the most enriched signaling pathways with miR-133a-3p. Comparing to injection of IPC-exo transfected with miR-133a-3p antagomir NC, injecting IPC-exo transfected with miR-133a-3p antagomir abolished protective effects of IPC-exo on declining excessive replacement fibrosis and cardiac function enhancement, while increasing the messenger RNA and protein expression of LTBP1, PPP2CA, and TGF-β 1in MI rats. Conclusion: IPC-exo inhibit excessive replacement fibrosis and improve cardiac function post-MI by transferring miR-133a-3p, the mechanism is associated with directly targeting LTBP1 and PPP2CA, and indirectly regulating TGF-β pathway in rats. Our finding provides potential therapeutic effect of IPC-induced exosomal miR-133a-3p for cardiac repair.
- Open Access
- 1 October 2023
- Published by Taylor & Francis in Journal of Pain Research
- Vol. ume 16, 3625-3632
Opioid-Free Anesthesia for Pain Relief After Laparoscopic Cholecystectomy: A Prospective Randomized Controlled Trial
Purpose: To compare the efficacies of opioid-free anesthesia (OFA) and opioid-based anesthesia (OBA) in laparoscopic cholecystectomy (LC). Patients and Methods: A total of 150 patients who underwent 3-port LC procedures were randomly divided into an OFA group with esketamine, dexmedetomidine and lidocaine intravenous combined with local anesthetic incision infiltration or an OBA group with remifentanil combined with local anesthetic incision infiltration. The primary outcome was the consumption of rescue analgesics within 24 hrs after surgery. Secondary outcomes included time to LMA removal, time to orientation recovery, time to unassisted walking, sleep quality on the night of surgery, time to first flatus, hemodynamics during induction of general anesthesia, postoperative pain level on the visual analog scale (VAS), incidence of postoperative nausea and vomiting (PONV) and global satisfaction score (GSS) within 24 hrs after surgery. Results: Both the consumption of rescue analgesics and the time to first flatus in the OFA group were significantly lower than those in the OBA group (P < 0.001 and P = 0.029, respectively). However, the time to LMA removal and the time to orientation recovery were significantly longer in the OFA group than in the OBA group (P < 0.001). In addition, the VAS scores at 2 hrs and 8 hrs after surgery and HR at laryngeal mask airway insertion in the OFA group were significantly lower than those in the OBA group (P = 0.002 and P = 0.001, and P =0.016, respectively). Conclusion: OFA may be beneficial for patients undergoing LC in that it could decrease the dosage of postoperative analgesics and pain intensity and even shorten the time to first flatus after surgery.
- 1 October 2023
- Published by Taylor & Francis in Journal of Pain Research
- Vol. ume 16, 3625-3632
Open AccessOpioid-Free Anesthesia for Pain Relief After Laparoscopic Cholecystectomy: A Prospective Randomized Controlled Trial
Purpose: To compare the efficacies of opioid-free anesthesia (OFA) and opioid-based anesthesia (OBA) in laparoscopic cholecystectomy (LC). Patients and Methods: A total of 150 patients who underwent 3-port LC procedures were randomly divided into an OFA group with esketamine, dexmedetomidine and lidocaine intravenous combined with local anesthetic incision infiltration or an OBA group with remifentanil combined with local anesthetic incision infiltration. The primary outcome was the consumption of rescue analgesics within 24 hrs after surgery. Secondary outcomes included time to LMA removal, time to orientation recovery, time to unassisted walking, sleep quality on the night of surgery, time to first flatus, hemodynamics during induction of general anesthesia, postoperative pain level on the visual analog scale (VAS), incidence of postoperative nausea and vomiting (PONV) and global satisfaction score (GSS) within 24 hrs after surgery. Results: Both the consumption of rescue analgesics and the time to first flatus in the OFA group were significantly lower than those in the OBA group (P < 0.001 and P = 0.029, respectively). However, the time to LMA removal and the time to orientation recovery were significantly longer in the OFA group than in the OBA group (P < 0.001). In addition, the VAS scores at 2 hrs and 8 hrs after surgery and HR at laryngeal mask airway insertion in the OFA group were significantly lower than those in the OBA group (P = 0.002 and P = 0.001, and P =0.016, respectively). Conclusion: OFA may be beneficial for patients undergoing LC in that it could decrease the dosage of postoperative analgesics and pain intensity and even shorten the time to first flatus after surgery.
- Open Access
- 21 September 2023
- Published by Elsevier in Journal of Anesthesia and Translational Medicine
- Vol. 2 (3) , 34-41
Postoperative Sore Throat After General Anesthesia: A Narrative Review
Endotracheal intubation is a common operation that provides effective mechanical ventilation under general anesthesia. Additionally, it may limit aspiration of upper airway content to the lower airways. However, endotracheal intubation is the prominent cause of airway mucosal injury, often resulting in postoperative sore throat (POST). Although POST is typically transient and mild, it can be a distressing complaint for adult patients following endotracheal intubation. The mechanisms underlying POST may be related to pressure stimulation of the tracheal wall by the trachea or tracheal cuff , as well as airway inflammation and throat damage during intubation and extubation. This present narrative review presents emerging data regarding the causes, risk factors and some common preventive measures for POST after general anesthesia and proposes a new intervention mode of POST. We searched relevant published articles in PubMed and Web of Science databases until January 2023 using key words including “postoperative sore throat”, “general anesthesia”, and “endotracheal intubation”.
- 21 September 2023
- Published by Elsevier in Journal of Anesthesia and Translational Medicine
- Vol. 2 (3) , 34-41
Open AccessPostoperative Sore Throat After General Anesthesia: A Narrative Review
Endotracheal intubation is a common operation that provides effective mechanical ventilation under general anesthesia. Additionally, it may limit aspiration of upper airway content to the lower airways. However, endotracheal intubation is the prominent cause of airway mucosal injury, often resulting in postoperative sore throat (POST). Although POST is typically transient and mild, it can be a distressing complaint for adult patients following endotracheal intubation. The mechanisms underlying POST may be related to pressure stimulation of the tracheal wall by the trachea or tracheal cuff , as well as airway inflammation and throat damage during intubation and extubation. This present narrative review presents emerging data regarding the causes, risk factors and some common preventive measures for POST after general anesthesia and proposes a new intervention mode of POST. We searched relevant published articles in PubMed and Web of Science databases until January 2023 using key words including “postoperative sore throat”, “general anesthesia”, and “endotracheal intubation”.
- 5 September 2023
- Published by Wolters Kluwer Health in Anesthesia & Analgesia
- Vol. 137 (4) , e39-e40
In Response
- 5 September 2023
- Published by Wolters Kluwer Health in Anesthesia & Analgesia
- Vol. 137 (4) , e39-e40
In Response